(PRWEB) October 29, 2013
Patheon, a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, will be showcasing a number of specialized softgel formulation technologies at the AAPS Annual Meeting and Exposition in San Antonio, Texas, November 10-14, 2013.
These innovative softgel technologies offer pharmaceutical companies additional access to innovative development options that maximize the value of their IP regardless of the phase of development. Many of Patheon’s top scientists and key executives will be on-hand throughout the conference at booth 2312 to showcase the technologies and discussion opportunities for collaboration. Attendees are encouraged to stop by to discuss the advantages and opportunities of these diverse softgel options in the context of their own projects. Patheon will be hosting two booth receptions: Monday, November 11th at 4:30 p.m. and Tuesday, November 12th at 4:45 p.m. Or to schedule a meeting in advance, you can email media(at)patheon(dot)com.
Patheon’s Anil Kane, Ph.D. leads Patheon’s scientific team in nearly 20 presentations.
It promises to be a busy AAPS for Patheon’s Executive Director, Global Science and Technology, Anil Kane and his scientific team. Dr. Kane will be making a presentation to the Recent Advances in Fixed-Dose Combination Therapy Symposium. Director of Global Technical Affairs, Dr. Stephen Closs will be making a presentation at the From Particle Engineering to Powder Processing Symposium. Other top scientists from Patheon will be presenting 16 scientific posters throughout the meeting. For a complete listing of all of Patheon’s public presentations, visit http://www.patheon.com/marketing/AAPS2013_schedule/index.html.
The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific association of approximately 11,000 members employed in industry, academia, government, and other research institutes worldwide. The AAPS Annual Meeting and Exhibition is a dynamic international forum where scientists, the media and the public can increase their understanding of the issues, advancements and opportunities facing public health today. For more information visit http://www.AAPS.org
Patheon Inc. (TSX: PTI) is a leading provider of high-quality contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid, sterile and softgel dosage forms. The company serves approximately 300 of the world’s leading pharmaceutical and biotechnology companies through an integrated network of 12 commercial manufacturing facilities and 9 product development centers across North America and Europe. Patheon enables customers to launch products with confidence anywhere in the world. For more information visit http://www.patheon.com